Nexstar Media Group Launches NEXTGEN TV in Denver, Marking the Company’s 12th Market and 22nd Station to Rollout ATSC 3.0 in 2020

Nexstar Media Group Launches NEXTGEN TV in Denver, Marking the Company’s 12th Market and 22nd Station to Rollout ATSC 3.0 in 2020

Nexstar Plans to Convert 32 More Stations in 20 Additional Markets in 2021

IRVING, Texas & DENVER–(BUSINESS WIRE)–
Nexstar Media Group, Inc. (Nasdaq: NXST) today announced that KDVR-TV and KWGN-TV, Nexstar Inc.’s local television stations serving the Denver, Colorado, area (DMA #16) have begun broadcasting with NEXTGEN TV, the revolutionary new digital broadcast technology powered by ATSC 3.0. Denver is Nexstar’s twelfth market to begin broadcasting with ATSC 3.0 this year, and the second top-20 market to do so.

Based on the same fundamental technology as the Internet, digital applications, and other web services, NEXTGEN TV can support a wide range of features currently in development, such as higher quality video and immersive audio, broadcasting to mobile devices, personalized viewing tools, and advanced emergency alerts. BitPath, the all-new broadcast data network launching in 2021, provides support for Nexstar’s ATSC 3.0 rollouts, and all of Nexstar’s ATSC 3.0 television stations will participate in the BitPath broadcast data network.

“With brilliant video and audio, NEXTGEN TV brings a whole new dimension to the television viewing experience and we are excited to rollout this advanced technology at Nexstar’s Denver stations,” said Brett Jenkins, Executive Vice President and Chief Technology Officer for Nexstar Media Group, Inc. “Not only does NEXTGEN TV deliver important upgrades for our viewers and advertisers, it also enables us to begin exploring new opportunities to use this very efficient and effective content and data distribution technology to meet the challenges of today’s evolving digital world. We plan to roll-out NEXTGEN TV to 32 more stations in 20 additional Nexstar markets in 2021, as we aggressively move forward implementing this highly sophisticated technology across the 115 markets we serve nationwide. When we finish our 2021 deployments, approximately 33% of all television households reached by a Nexstar television station will receive a NEXTGEN TV signal. I am incredibly proud of the leadership of our stations in making continued, tangible progress towards bringing NEXTGEN TV to a significant portion of the United States.”

Following today’s launch, the full list of Nexstar owned or operated stations/markets that have converted to NEXTGEN TV this year includes:

STATION

MARKET

DMA

WFLA

Tampa, FL

13

KDVR / KWGN

Denver, CO

16

KOIN / KRCW

Portland, OR

21

WNCN

Raleigh, NC

24

WKRN

Nashville, TN

29

KTVX / KUCW

Salt Lake City, UT

30

KXAN / KNVA / KBVO-CD

Austin, TX

38

KLAS

Las Vegas, NV

40

KFOR / KAUT

Oklahoma City, OK

44

WAVY / WVBT / WNLO-CD

Norfolk, VA

46

WKRG / WFNA

Mobile, AL

57

WWLP / WFXQ-CD

Springfield, MA

116

Today’s launch in Denver follows a decade of development of the new technology and months of planning and preparation by Nexstar Inc. Current programming remains available to all of Nexstar’s viewers in all of its markets, regardless of whether their television service is provided over-the-air or by a cable or satellite company. Antenna viewers can simply rescan their TV sets to ensure full service. Rescan instructions are available at: fcc.gov/rescan. Cable and satellite subscribers do not need to take any action.

About Nexstar Media Group, Inc.

Nexstar Media Group (NASDAQ: NXST) is a leading diversified media company that leverages localism to bring new services and value to consumers and advertisers through its traditional media, digital and mobile media platforms. Its wholly owned operating subsidiary, Nexstar Inc., consists of three divisions: Broadcasting, Digital, and Networks. The Broadcasting Division operates, programs, or provides sales and other services to 197 television stations and related digital multicast signals reaching 115 markets or approximately 39% of all U.S. television households (reflecting the FCC’s UHF discount). The division’s portfolio includes primary affiliates of NBC, CBS, ABC, FOX, MyNetworkTV and The CW. The Digital Division operates 122 local websites and 316 mobile apps offering hyper-local content and verticals for consumers and advertisers, allowing audiences to choose where, when and how they access content and creating new revenue opportunities for the company. The Networks Division operates WGN America, a growing national general entertainment cable network and the home of NewsNation, multicast network Antenna TV, and WGN Radio in Chicago. Nexstar also owns a 31.3% ownership stake in TV Food Network, a top tier cable asset. For more information please visit www.nexstar.tv.

MEDIA CONTACT

Gary Weitman

EVP/Chief Communications Officer

Nexstar Media Group, Inc.

312/222-3394 or [email protected]

INVESTOR CONTACT

Joe Jaffoni or Jennifer Neuman

JCIR

212/835-8500 or [email protected]

KEYWORDS: United States North America Texas Colorado

INDUSTRY KEYWORDS: Other Communications Technology Audio/Video Communications General Entertainment Other Consumer Women TV and Radio Men Other Technology Telecommunications Entertainment Consumer Internet Mobile/Wireless

MEDIA:

Logo
Logo

JPM Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds JPMorgan Chase & Co. Shareholders of Class Action and Lead Plaintiff Deadline: December 23, 2020

NEW YORK, Dec. 23, 2020 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against of JPMorgan Chase & Co. (“JP Morgan” or “the Company”) (NYSE: JPM) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired JPMorgan securities between February 23, 2016 and September 23, 2020, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/jpm.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) traders at the Company, with the knowledge and consent of their superiors, manipulated the precious metals market by “spoofing,” or placing fake orders to generate the appearance of market demand; (2) the Company had insufficient controls and compliance protocols to enable it to identify and stop the misconduct; (3) the Company’s earnings in the physical commodity market were, at least in part, ill-gotten; (4) such conduct would result in enhanced regulatory scrutiny; (5) the Company provided misleading information to CFTC investigators at early stages of the investigation into the misconduct; (6) resolution of the governmental investigation into the Company would result in a record-breaking $920 million fine; and (7) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/jpm or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in JPMorgan you have until December 23, 2020 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]



Orbus Therapeutics Receives U.S. Patent for Eflornithine Formulations

– Patent relates to a solution of eflornithine for oral administration currently being evaluated in Orbus’ Phase 3 STELLAR study in rare brain cancer –

PALO ALTO, Calif., Dec. 23, 2020 (GLOBE NEWSWIRE) — Orbus Therapeutics Inc., a private, late-stage biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases, announced that it has been granted patent No. 10,786,470 entitled “Formulations for Administration of Eflornithine,” by the United States Patent and Trademark Office (USPTO).

The patent, which was granted on September 29, 2020, covers a solution of eflornithine hydrochloride hydrate for oral administration and methods of use for treating gliomas including anaplastic astrocytoma.

Orbus is currently evaluating eflornithine in an ongoing Phase 3 clinical trial, the STELLAR study, in patients with anaplastic astrocytoma whose cancer has recurred following radiation and adjuvant chemotherapy. In controlled, randomized and single arm clinical studies, eflornithine has shown an increase in overall survival of patients with newly diagnosed or recurrent anaplastic astrocytoma.

About Eflornithine

Eflornithine is a novel cytostatic agent that irreversibly inhibits ornithine decarboxylase, a key enzyme in mammalian polyamine biosynthesis that is up-regulated in certain types of cancer. In controlled, randomized and single arm clinical studies, eflornithine has shown an increase in overall survival of patients with newly diagnosed or recurrent anaplastic astrocytoma.

Eflornithine has been granted Orphan Drug Designation and Breakthrough Therapy Designation for the treatment of patients with anaplastic glioma by the U.S. Food and Drug Administration (FDA), and has also been granted Orphan Medicinal Product status for the treatment of glioma by the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA).

About Orbus Therapeutics

Orbus Therapeutics is a late-stage, private biopharmaceutical company that is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The Company’s lead product candidate, eflornithine, is being evaluated in a pivotal Phase 3 clinical trial in patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. For more information, please visit the Company’s website at http://www.orbustherapeutics.com

Source: Orbus Therapeutics, Inc.



Investor Contact:
Jason Levin, COO
[email protected]
650.656.9440

Media Contact:
Denise Powell
[email protected]
510.703.9491

IZEA Managed Services Bookings Top 40% Growth in Q4 to Hit Record

Orlando, Florida, Dec. 23, 2020 (GLOBE NEWSWIRE) — IZEA Worldwide, Inc. (NASDAQ: IZEA), the premier provider of influencer marketing technology, data, and services for the world’s leading brands, announced today that it has set a Managed Services bookings record for the best Q4 in company history. The announcement comes just one week after IZEA reported besting its Q4 2019 Managed Services bookings number. Since that time, IZEA has added a variety of new contracts from both first-time customers as well as existing customers. IZEA’s Managed Services bookings have now climbed 40% year over year despite the impact the pandemic has had on a portion of IZEA’s historical customer base.

“I cannot remember a time in our 14-year history when the cadence of customer contracts has been this strong,” said Ted Murphy, IZEA’s Chairman and CEO. “Not only have we seen our new customer counts for Managed Services more than double from Q3 to Q4, we have also seen our loyal customer base return with strength. Many of them are not only increasing their commitments for the 2020 holiday season, but also kickstarting their 2021 influencer marketing initiatives.”

The count of new IZEAx Unity Suite customer contracts signed has also set a company record in Q4, surpassing the previous benchmark reached during Q1 of this year. The expansion of new Unity Suite customers has been positively impacted by more affordable and flexible licensing options that were first introduced toward the end of Q3 2020. IZEA’s total active SaaS customer base has reached record numbers in Q4 2020, largely driven by IZEAx Discovery, the company’s self-service offering.

“Our push to increase the diversity of our customer base is starting to be realized in both SaaS and Managed Services,” continued Murphy. “From contracts with the U.S. Military and Fortune 10 Retailers to Smaller Agencies and DTC Brands, we are being awarded contracts more often from a wider variety of buyers. Not only is that better for our company, it also drives more opportunity for the different types of influencers we serve. We are pushing hard to close out 2020 with momentum and look forward to the new year.”

About IZEA Worldwide, Inc.

IZEA Worldwide, Inc. (“IZEA”) operates IZEAx, the premier online marketplace that connects marketers with content creators. IZEAx automates influencer marketing and custom content development, allowing brands and agencies to scale their marketing programs. IZEA creators include celebrities and accredited journalists. Creators are compensated for producing unique content such as long and short form text, videos, photos, status updates, and illustrations for marketers or distributing such content on behalf of marketers through their personal websites, blogs, and social media channels. Marketers receive influential content and engaging, shareable stories that drive awareness. For more information about IZEA, visit https://izea.com/.

Safe Harbor Statement

All statements in this release that are not based on historical fact are “forward-looking statements” intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “may,” “will,” “would,” “could,” “should,” “expect,” “anticipate,” “hope,” “estimate,” “believe,” “intend,” “likely,” “projects,” “plans,” “pursue,” “strategy” or “future,” or the negative of these words or other words or expressions of similar meaning.  Examples of forward-looking statements include, among others, statements we make regarding expectations concerning IZEA’s ability to increase revenue and bookings, growth or maintenance of customer relationships, and expectations concerning IZEA’s business strategy. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, as a result of various factors including, among others, the following: competitive conditions in the content and social sponsorship segment in which IZEA operates; failure to popularize one or more of the marketplace platforms of IZEA; our ability to establish effective disclosure controls and procedures and internal control over financial reporting; our ability to satisfy the requirements for continued listing of our common stock on the Nasdaq Capital Market; changing economic conditions that are less favorable than expected; and other risks and uncertainties described in IZEA’s periodic reports filed with the Securities and Exchange Commission. The forward-looking statements made in this release speak only as of the date of this release, and IZEA assumes no obligation to update any such forward-looking statements to reflect actual results or changes in expectations, except as otherwise required by law.



Martin Smith
IZEA Worldwide, Inc.
Phone: 407-674-6911
Email: [email protected]

Help Lightning Announces Banner Year for Growth

Company achieves 110% increase in customer base for its virtual expertise software; New enterprise customers include Pfizer, Cox Communications, Abbott Labs, Ortho-Clinical Diagnostics, and Nestle Health Science

BIRMINGHAM, Ala., Dec. 23, 2020 (GLOBE NEWSWIRE) — Help Lightning, Inc., a provider of virtual expertise software that enables enterprises to accelerate the transformation of their field service and call center organizations from cost centers to profit centers, today announced exponential customer growth in 2020, which increased 110% over 2019. Help Lightning added numerous global enterprise customers during the year, including Pfizer, Cox Communications, Abbott Labs, Ortho-Clinical Diagnostics, and Nestle Health Science. This announcement comes on the heels of the company recently closing an $8m Series A funding round led by Resolve Growth Partners.

Summary year-over-year highlights include:

  • New customer acquisition increased 110%
  • New enterprise customers include Pfizer, Cox Communications, Abbott Labs, Ortho-Clinical Diagnostics, and Nestle Health Science
  • Customer usage (measured in call volume) increased 457%
  • Enterprise users increased 133%
  • $8m Series A funding round led by Resolve Growth Partners

“Help Lightning had an extraordinary year, with our virtual expertise software playing a vital role in bringing technical expertise to settings where it’s most urgently needed,” said Gary York, CEO, Help Lightning. “While the pandemic has caused an extraordinary spike in global demand, our customers are seeing so much efficiency gain, cost reduction, and fix rate improvement, they are reporting that there is no going back to the old way of doing business.”

Help Lightning had a compelling value proposition prior to the pandemic for service organizations including reducing the time to problem resolutions, eliminating truck rolls, and reducing first time fix rate. When the COVID-19 pandemic caused global shutdowns and travel restrictions, Help Lightning’s virtual expertise software transitioned from reducing costs and increasing customer satisfaction to being mission critical to support service operations for global companies.

When the pandemic hit, Help Lightning became a key tool for companies to be able to continue to serve their customers. For companies with critical installations in countries throughout the world, travel restrictions prevented experts from getting there. Companies evolved their service model using Help Lightning to guide local technicians through proper installations and maintenance.

Today hundreds of field service organizations and call centers across a variety of industries rely on Help Lightning’s virtual expertise software to remotely deliver expertise by connecting people with the knowledge to the people trying to solve the problem. Whether facing workforce attrition, quality and responsiveness issues, or the inability to measure field service performance, Help Lightning enables organizations to do more with less and accelerate the transformation of their field service organizations from cost centers to profit centers.

About Help Lightning

Help Lightning, Inc. provides virtual expertise software to hundreds of companies across a variety of industries with users in over 90 countries. Enterprise companies such as Becton Dickinson, Boston Scientific, Siemens and Pfizer depend on Help Lightning to improve their field service organization and call center first-time fix rates, extend their workforce capacity, and improve customer satisfaction. Unlike other remote technology solutions, only Help Lightning combines easy-to-use software with industry-specific expertise and a partnership approach to help its customers accelerate their digital transformation. For more information, visit www.helplightning.com.

Contact:
Jake Katz
Email: [email protected] 



CSX Corp. Announces Date for Fourth-Quarter Earnings Release and Earnings Call

JACKSONVILLE, Fla., Dec. 23, 2020 (GLOBE NEWSWIRE) — CSX Corp. (NASDAQ: CSX) will release fourth-quarter financial and operating results after the market close on Thursday, January 21, 2021. This will be followed by a conference call and live webcast hosted by the company’s management team at 4:30 p.m. Eastern Time.

Those interested in participating via teleconference may dial 1-866-324-3683. Callers outside the U.S. may dial 1-509-844-0959. Participants should dial in 10 minutes prior to the call and use 2874369 as the passcode.

Presentation materials and access to the webcast will be available on the company’s website at http://investors.csx.com. Following the earnings call, a webcast replay will be archived on the company’s website.

About CSX and its Disclosures

CSX, based in Jacksonville, Florida, is a premier transportation company. It provides rail, intermodal and rail-to-truck transload services and solutions to customers across a broad array of markets, including energy, industrial, construction, agricultural, and consumer products. For nearly 200 years, CSX has played a critical role in the nation’s economic expansion and industrial development. Its network connects every major metropolitan area in the eastern United States, where nearly two-thirds of the nation’s population resides. It also links more than 230 short-line railroads and more than 70 ocean, river and lake ports with major population centers and farming towns alike.

This announcement, as well as additional financial information, is available on the company’s website at http://investors.csx.com. CSX also uses social media channels to communicate information about the company. Although social media channels are not intended to be the primary method of disclosure for material information, it is possible that certain information CSX posts on social media could be deemed to be material. Therefore, we encourage investors, the media, and others interested in the company to review the information we post on Twitter (http://twitter.com/CSX) and on Facebook (http://www.facebook.com/OfficialCSX). The social media channels used by CSX may be updated from time to time. More information about CSX Corporation and its subsidiaries is available at www.csx.com.

Contact:

Bill Slater, Investor Relations
904-359-1334

Bryan Tucker, Corporate Communications
855-955-6397



Playing to WIN: CEO’s of Activision Blizzard, FansUnite, NetEase, and GAN Limited Driving New Revenue Growth Opportunities in E-Sports, and Digital Entertainment

NEW YORK, Dec. 23, 2020 (GLOBE NEWSWIRE) — Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Activision Blizzard, Inc. (NASDAQ: ATVI), NetEase (NASDAQ: NTES) FansUnite (OTC: FUNFF) (CSE: FANS), and GAN Limited (NASDAQ: GAN)

Digital Entertainment is emerging as the dominant growth theme of the decade, with billions of dollars in revenues generated worldwide from video games, streaming to online casinos and sports betting. Wall Street Reporter highlights the latest comments from industry thought leaders:

Activision Blizzard, Inc. (NASDAQ: ATVI) CEO Bobby Kotick: “Billion Dollar Entertainment Franchises – With Momentum”

“…We now expect net bookings in 2020 to grow over 25% year-over-year with earnings per share growing even faster. Since refocusing our teams on our greatest opportunities, we’ve started to return to the execution excellence, we’ve always been known for. We have significantly grown the number of creative and commercial employees working on our key franchises. …We’re in a position to deliver sustained and significant long-term expansion across our portfolio of fully owned franchises. As we execute against our content pipeline to extend our key franchises to mobile, introduce new free-to-play experiences and continue to optimize in-game operations we are positioned to continue converting our growing engagement into consistent and long-term revenue and earnings growth.”

“…Call of Duty is the first community to benefit from our pursuit of this franchise based strategy. With over 100 million monthly players, the Call of Duty community is larger than ever before. And with expansion across all platforms the franchise has transformed into a truly social experience that engages and connects our players in truly epic ways. By expanding to mobile, we’ve brought in tens of millions of new players in countries far beyond our traditional audiences. With the game now in final large-scale testing in China and over 50 million players already preregistered, we see a clear path to continue growing Call of Duty’s reach, engagement, and player investment on mobile in the largest mobile gaming market in the world.”

“…There are few entertainment franchises that generate over $1 billion in annual net bookings. And today we operate three of them: Call of Duty World of Warcraft and Candy Crush. And each has clear opportunity for sustained growth…For the balance of this year, we’re raising our outlook and we believe we will continue connecting and engaging more players than ever before in 2021.”

Activision Blizzard, Inc. (NASDAQ: ATVI) Q3 2020 Earning Highlights:


http://bit.ly/34ExR9O

FansUnite (OTC: FUNFF) (CSE: FANS) “Positioned for Exponential Revenue Growth in iGaming, E-Sports, Online Sports Betting”

In a recent presentation at Wall Street Reporter’s NEXT SUPER STOCK livestream, FansUnite (OTC: FUNFF) (CSE: FANS) CEO Scott Burton explained how the company’s latest distribution deal with a online casino games aggregator, sets the stage for exponential revenue growth opportunities. In the next 12 months, FUNFF plans to expand its current line from three games to twelve – while adding multiple aggregators for each game – reaching millions of new online casino customers worldwide. With each game generating as much as $500,000 in revenue per month for FUNFF – per online casino – and the potential to be in hundreds of online casinos – these numbers can quickly add up.

Watch FansUnite (OTC: FUNFF) NEXT SUPER STOCK 12/9/20 VIDEO:


http://bit.ly/3phwp53

December 16 – FUNFF gains first-mover advantage into the U.S. esports betting market, as it’s long-term partner GameCo joins US Bookmaking and Sky Ute Casino to establish the first dedicated esports sportsbook in the United States. FUNFF wholly-owned subsidiary Askott Entertainment will supply its iGaming platform, Chameleon, as part of a fully integrated esports betting solution. Through GameCo’s partnership with Sky Ute Casino and US Bookmaking, FansUnite will be the first iGaming solutions provider to receive significant exposure in the U.S. esports betting market.

December 7 – FUNFF receives Malta Gaming Service License and Critical Gaming Supply, and will now be able to offer a full spectrum of online gambling services in Europe, covering Casino, Fixed Odds Betting, Pool Betting and Controlled Skilled Games. With MGA approval received, FansUnite will be joining other highly respected gambling companies such as PokerStars, Betfair and Unibet in operating their business within MGA regulations.

Nov 5 – FUNFF’s wholly-owned UK Sportsbook McBookie achieves record 433% increase in revenue and 713% increase in gross margin in October 2020 compared to October 2019. Much of the growth was attributed to the unveiling of McBookie’s live casino games and increased activity in sports betting which resulted in $7.3M in total betting volume being placed during the month

Watch FansUnite (OTC: FUNFF) NEXT SUPER STOCK 12/9/20 VIDEO:


http://bit.ly/3phwp53

GAN Limited (NASDAQ: GAN) CEO Dermot Smurfit: “
On Path To $100 Million Revenue with Online Sports Betting and Casinos”

“..While both the consumer attention and client demand remains focused on sports betting, the real core of the U.S. internet gambling profit opportunity lies inherently within the online casino, which is only unlocked by the mass market appeal of sports betting being a technical and operational capability, we will shortly possess…”

“When you combine online casino gaming with internet poker, and of course, internet sports betting, New Jersey generated in excess of $132 million of gross operating revenue in that single state in the single month of October. This amount would have seemed implausible just two years ago. New Jersey is now on a path where internet gambling revenues could be on a monthly run rate to exceed pre-COVID retail gaming revenues by the end of 2022. I’ll state this again, because it is incredibly important for everyone to understand the magnitude of the structural shift in the retail casino industry. New Jersey’s internet gambling market is on a growth path to exceed pre-COVID monthly retail casino gaming revenues within 18 months, possibly less. This all points to bright line a truth that COVID combined with the advent of internet sports betting and the associated strong cross-sell of sports gamblers into online casino gaming has manifestly altered expected future growth opportunities in this industry for decades to come…Our continuing mission is to bring retail casinos online with our technology platform focused principally on delivering all forms of internet gambling content, including casino gaming and sports betting.”

“‘…The largest event in 2020 for shareholders appears not to be an admission to trading on NASDAQ, but the inflection point represented by or now announced acquisition of Coolbet with regulated operations in both Europe and Latin America…This acquisition accelerates our previously announced pathway to $100 million in topline revenues. It unlocks the shareholder value opportunity to become a B2B sports betting provider in the U.S. and provides us with a fast growing internal — international strategy, which is entirely incremental to our existing international market activity in Italy.”

GAN Limited (NASDAQ: GAN) Q3 2020 Earnings Highlights:


https://bit.ly/32QlM0m

NetEase (NASDAQ: NTES) CEO William Ding: ”Building Global Leader in Digital Entertainment”

“…We grew our net revenues year-over-year by nearly 26% to RMB18.2 billion for this quarter, and our net income from continuing operations attributable to our shareholders grew year-over-year by 35% to RMB4.5 billion.Our online games was up 21% in the second quarter year-over-year, reaching net revenue of RMB13.8 billion, driven by the impressive strength of our existing titles. Our flagship, Fantasy Westward Journey series and Westward Journey series, continued their strong performance in the second quarter. As two of the largest and longest-running game IPs in China, both games consistently attract a loyal crowd…”

“…We are very committed to bringing the richest content to Chinese users by introducing exciting global music and incubating independent musicians. In the second quarter, we launched numerous paid live shows for independent bands, giving them more options to stream online during this uncertain time…Beyond our progress in the domestic market, we have also made multiple headway with our international initiatives. Our overseas online game net revenues hit a new record high in the second quarter, propelled by robust performances from Knives Out and Life-After in Japan…”

“…NetEase is best known for our content creation capabilities. This rings true across our different business segments. As we look to the second half of this year, we are more confident and committed than ever to further expanding our reach and bringing relevant, exciting, new products and services to NetEase players, fans and followers around the world…We are excited to lead our next wave of expansion as we continue to build value for all of our stakeholders…”

NetEase (NASDAQ: NTES) Q2 2020 Earnings Highlights:


https://bit.ly/3kFMNK9

WALL STREET REPORTER

Wall Street Reporter (Est. 1843) is the leading financial news provider, focused on giving investors direct access to CEO’s of promising, publicly-traded companies, and market experts. www.WallStreetReporter.com

About Wall Street Reporter’s Next Super Stock conference:

Wall Street Reporter’s NEXT SUPER STOCK Live! conference is dedicated to featuring select companies that have near-term catalysts in place which can drive transformational growth (and stock appreciation) in the months ahead. Click here to join next livestream event: https://www.wallstreetreporter.com/next-superstock-online-investor-conference/

CONTACT:

WALL STREET REPORTER

(212) 871-2057 ext 7


www.WallStreetReporter.com



Hoth Therapeutics Submits Request for a Pre-Investigational New Drug (Pre-IND) Meeting for HT-001, Treatment for Cancer Patients

PR Newswire

NEW YORK, Dec. 23, 2020 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced the request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-001, a topical drug formation under development for the treatment of rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy. EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

Cancer patients receiving EGFR inhibitor therapy often require repeat courses to achieve effective cancer treatment, and >50% of patients have significant dermatological side effects within the first 2 weeks of treatment that persist even after stopping EGFR therapy. These skin toxicities can severely impact patient quality of life and can result in reduction of EGFR inhibitor dose or interruption of treatment. HT-001 is targeted to treat these EGFR-induced skin disorders to allow patients to achieve the best potential outcomes of EGFR therapy, as there are currently no approved drugs to specifically treat EGFR inhibitor-induced skin disorders.

In July 2019 Hoth Therapeutics entered into a Sponsored Research Agreement with the George Washington University (GW) to explore preclinical pharmacology studies with topically administered HT-001.

Currently in the preclinical stage of development of HT-001, Hoth Therapeutics anticipates a meeting with the FDA to be scheduled during the first quarter of 2021. HT-001 is being positioned for submission via the 505(b)(2) development pathway, in which Hoth Therapeutics intends to rely on information not obtained through right of reference in order to reduce the nonclinical and clinical program and expedite time to NDA submission. During the pre-IND meeting with the FDA, Hoth Therapeutics plans to discuss the overall proposed drug development program for HT-001 including requirements for nonclinical, clinical pharmacology, clinical, and chemistry, manufacturing, controls. Hoth also plans to present clinical trial designs for the IND-opening, phase 2a dose ranging study as well as a proposed follow-up phase 2b safety and efficacy dose extension study; both studies will be conducted in cancer patients receiving EGFR inhibitor therapy.

“Palliative care treatment for cancer patients continues to be an underserved segment of the market that our HT-001 product has an opportunity to provide patients with a better quality of life during their cancer treatment,” stated Robb Knie, Chairman and CEO of Hoth Therapeutics. “We look forward to working closely with the FDA on our Phase 2a and Phase 2b trial designs and advancing HT-001 through the research and development process.”

About Hoth Therapeutics, Inc. 
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders. Hoth’s pipeline has the potential to improve the quality of life for patients suffering from indications including atopic dermatitis, chronic wounds, psoriasis, asthma and acne. Hoth has also recently entered into two different agreements to further the development of two different therapeutic prospects to prevent or treat COVID-19. To learn more, please visit www.hoththerapeutics.com .

Forward-Looking Statement 
This press release includes forward-looking statements based upon Hoth’s current expectations which may constitute forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995 and other federal securities laws, and are subject to substantial risks, uncertainties and assumptions. These statements concern Hoth’s business strategies; the timing of regulatory submissions; the ability to obtain and maintain regulatory approval of existing product candidates and any other product candidates we may develop, and the labeling under any approval we may obtain; the timing and costs of clinical trials, the timing and costs of other expenses; market acceptance of our products; the ultimate impact of the current Coronavirus pandemic, or any other health epidemic, on our business, our clinical trials, our research programs, healthcare systems or the global economy as a whole; our intellectual property; our reliance on third party organizations; our competitive position; our industry environment; our anticipated financial and operating results, including anticipated sources of revenues; our assumptions regarding the size of the available market, benefits of our products, product pricing, timing of product launches; management’s expectation with respect to future acquisitions; statements regarding our goals, intentions, plans and expectations, including the introduction of new products and markets; and our cash needs and financing plans. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. You should not place reliance on these forward-looking statements, which include words such as “could,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “may,” “continue,” “predict,” “potential,” “project” or similar terms, variations of such terms or the negative of those terms. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee such outcomes. Hoth may not realize its expectations, and its beliefs may not prove correct. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including, without limitation, market conditions and the factors described in the section entitled “Risk Factors” in Hoth’s most recent Annual Report on Form 10-K and Hoth’s other filings made with the U. S. Securities and Exchange Commission. All such statements speak only as of the date made. Consequently, forward-looking statements should be regarded solely as Hoth’s current plans, estimates, and beliefs. Investors should not place undue reliance on forward-looking statements. Hoth cannot guarantee future results, events, levels of activity, performance or achievements. Hoth does not undertake and specifically declines any obligation to update, republish, or revise any forward-looking statements to reflect new information, future events or circumstances or to reflect the occurrences of unanticipated events, except as may be required by applicable law.

Investor Contact: 
LR Advisors LLC 
Email: [email protected]
www.hoththerapeutics.com
Phone: (678) 570-6791

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/hoth-therapeutics-submits-request-for-a-pre-investigational-new-drug-pre-ind-meeting-for-ht-001-treatment-for-cancer-patients-301197951.html

SOURCE Hoth Therapeutics, Inc.

Vanguard Announces Final Cash Distributions for the Vanguard ETFs (VBU, VBG and VGAB)

Canada NewsWire

TORONTO, Dec. 23, 2020 /CNW/ – Vanguard Investments Canada Inc. today announced the final December 2020 cash distributions for certain Vanguard ETFs, listed below, that trade on Toronto Stock Exchange (TSX).

Unitholders of record on December 24, 2020 will receive cash distributions payable on January 5, 2021. Please be advised that the distributions announced in this press release are the same as those stated in the December 17, 2020 press release for these funds.

Details of the “per unit” distribution amounts are as follows: 


Vanguard ETF®


TSX
Ticker
Symbol


Distribution
per Unit ($)


CUSIP


ISIN


Payment
Frequency

Vanguard U.S. Aggregate Bond Index ETF (CAD-
hedged)

VBU

0.067017

92206G103

CA92206G1037

Monthly

Vanguard Global ex-U.S. Aggregate Bond Index
ETF (CAD-hedged)

VBG

0.047142

92206H101

CA92206H1010

Monthly

Vanguard Global Aggregate Bond Index ETF
(CAD-hedged)

VGAB

0.053025

92211F108

 

CA92211F1080

 

Monthly

To learn more about the TSX-listed Vanguard ETFs, please visit www.vanguardcanada.ca

About Vanguard

Canadians own CAD $49 billion in Vanguard assets, including Canadian and U.S.-domiciled ETFs, Canadian institutional products and Canadian mutual funds. Vanguard Investments Canada Inc. manages CAD $31 billion in assets (as of November 30, 2020) with 37 Canadian ETFs and four mutual funds currently available. The Vanguard Group, Inc. is one of the world’s largest investment management companies and a leading provider of company-sponsored retirement plan services. Vanguard manages USD $6.3 trillion (CAD $8 trillion) in global assets, including over USD $1.4 trillion (CAD $1.8 trillion) in global ETF assets (as of October 31, 2020). Vanguard has offices in the United States, Canada, Mexico, Europe, Australia and Asia. The firm offers 421 funds, including ETFs, to its more than 30 million investors worldwide.

Vanguard operates under a unique operating structure. Unlike firms that are publicly held or owned by a small group of individuals, The Vanguard Group, Inc. is owned by Vanguard’s U.S.-domiciled funds and ETFs. Those funds, in turn, are owned by Vanguard clients. This unique mutual structure aligns Vanguard interests with those of its investors and drives the culture, philosophy, and policies throughout the Vanguard organization worldwide. As a result, Canadian investors benefit from Vanguard’s stability and experience, low-cost investing, and client focus. For more information, please visit vanguardcanada.ca.

Important information

Commissions, management fees, and expenses all may be associated with investment funds. Investment objectives, risks, fees, expenses, and other important information are contained in the prospectus; please read it before investing. Investment funds are not guaranteed, their values change frequently, and past performance may not be repeated. Vanguard funds are managed by Vanguard Investments Canada Inc. and are available across Canada through registered dealers.

SOURCE Vanguard Investments Canada Inc.

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against OrthoPediatrics Corp. and Encourages Investors with Losses of $100,000 to Contact the Firm

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against OrthoPediatrics Corp. and Encourages Investors with Losses of $100,000 to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of OrthoPediatrics Corp. (“OrthoPediatrics” or “the Company”) (NASDAQ: KIDS) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. OrthoPediatrics is the subject of a report published by Culper Research on December 2, 2020, titled: “OrthoPediatrics Corp. (KIDS): Even Channel Stuffing Can’t Save This Company.” The report alleges that the Company has “engaged in a channel stuffing scheme that has systematically and significantly overstated revenues.” Culper adds that “the Company has abused its ability to book revenues upon shipment by selling and shipping excess product directly to its distributors, many of whom are exclusive to the Company.” Culper further states it is “concerning that many of the Company’s ‘exclusive distributors’ are simply former OrthoPediatrics employees who have formed their own distributorships, often while still employed at the Company.” Based on this report, shares of OrthoPediatrics dropped by more than 9% on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

The Schall Law Firm

Brian Schall, Esq.

310-301-3335

[email protected]

www.schallfirm.com

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo